ReviewCancers2022

Neoadjuvant Treatment with HER2-Targeted Therapies in HER2-Positive Breast Cancer: A Systematic Review and Network Meta-Analysis.

Agampodi Danushi M Gunasekara et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.